Come up with a name for your new list and we'll add to it:
Vedantra Pharmaceuticals raised a round of funding on , . Investors include
Clal Biotechnology Industries.
Vendantra Pharmaceuticals aims to improve immunotherapy outcomes by enhancing adaptive immune responses. Vedantra's platform technologies are able to deliver agents directly to the antigen-presenting …